| HIV integrase | <enzyme> Enzyme of the human immunodeficiency virus that is required to integrate viral DNA into cellular DNA in the nucleus of a host cell. HIV integrase is a DNA nucleotidyltransferase encoded by the pol gene. Registry number: EC 2.7.7.- (12 Dec 1998) |
|---|---|
| HIV integrase inhibitors | Inhibitors of HIV integrase, an enzyme required for integration of viral DNA into cellular DNA. (12 Dec 1998) |
| HIV long-terminal repeat | Regulatory sequences important for viral replication that are located on each end of the HIV genome. The ltr includes the HIV enhancer, promoter, and other sequences. Specific regions in the ltr include the negative regulatory element (nre), nf-kappa b binding sites , sp1 binding sites, tata box, and trans-acting responsive element (tar). The binding of both cellular and viral proteins to these regions regulates HIV transcription. (12 Dec 1998) |
| HIV protease | <enzyme> Enzyme of the human immunodeficiency virus that is required for post-translational cleavage of gag and gag-pol precursor polyproteins into functional products needed for viral assembly. HIV protease is an aspartic protease encoded by the amino terminus of the pol gene. Registry number: EC 3.4.23.- (12 Dec 1998) |
| HIV protease inhibitors | Inhibitors of HIV protease, an enzyme required for production of proteins needed for viral assembly. (12 Dec 1998) |
| HIV seronegativity | Immune status consisting of non-production of HIV antibodies, as determined by various serological tests. (12 Dec 1998) |
| HIV seropositivity | Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/lav). (12 Dec 1998) |
| HIV seroprevalence | Studies of the number of cases where human immunodeficiency virus (HIV) is present in a specific population at a designated time. The presence in a given individual is determined by the finding of HIV antibodies in the serum (HIV seropositivity). (12 Dec 1998) |
| HIV test | <investigation> A test which is performed on a standard venipuncture blood specimen which detects the presence of antibodies to HIV (virus). This test may not be positive for 3 to 6 months after infection with HIV. (27 Sep 1997) |
| HIV wasting syndrome | <syndrome> Involuntary weight loss of greater than 10 percent associated with intermittent or constant fever and chronic diarrhoea or fatigue for more than 30 days in the absence of a defined cause other than HIV infection. A constant feature is major muscle wasting with scattered myofibre degeneration. A variety of aetiologies, which vary among patients, contributes to this syndrome. (12 Dec 1998) |
| agonal infection | An acute infection, commonly pneumonic or septic, occurring toward the end of any disease and often the cause of death. Synonym: agonal infection. (05 Mar 2000) |
| airborne infection | A mechanism of transmission of an infectious agent by particles, dust, or droplet nuclei suspended in the air. (05 Mar 2000) |
| apical infection | Implantation of microorganisms at the apex of a tooth, usually the result of the migration of microorganisms from the pulp canal through the apical foramen. (05 Mar 2000) |
| arbovirus infection | <virology> A type of viral infection that is transmitted by mosquitoes in late spring to early autumn. One manifestation is encephalitis (central nervous system infection). (27 Sep 1997) |
| ascariasis infection | <microbiology> Infection by the nematode Ascaris lumbricoides and is characterised by an early pulmonary phase related to larval migration and a later, prolonged intestinal phase. Adult worms are 15-40 cm in length and maintain themselves in the lumen of the small intestine. Infection occurs after ingesting eggs contained in contaminated food or more commonly, by transmission to the mouth by the hands after contact with contaminated soil. Treatment is with mebendazole or pyrantel pamoate. (27 Sep 1997) |